Prof. Sayed-Ahmed’s team discovered that long-term carnitine supplements may even prevent the development of liver cancer. In their study using lab rats as animal model, they observed that a depletion in L carnitine levels led to the development of pre-malignant lesions in the liver and also progressed the vital organ’s degeneration. Providing carnitine supplements were found to completely reverse the degradation and the pre-cancerous lesions in the river also disappeared.

More at carnitine supplements and liver cancer.

Also check out: vitamins alpha lipoic acid.

Korean scientists have developed a substance they call “TSAHC,” which is to be used for a new medicine that could suppress the protein TM4SF5 known to be a major cause of liver cancer.

Lee Jung-weon, a professor at the College of Medicine of Seoul National University, and Park Ki-hun, a professor of applied life sciences at Gyeongsang National University made the announcement on Monday. Their paper is listed in the online version of world-renowned journal Hepatology, after the research team finished registering patents on TSAHC in Korea and the United States.

“TSAHC has fewer side effects than existing anti-cancer medicine that kills cancer cells, because it selectively suppresses tumor growth and growth of cells in veins that supply nutrition to cancer cells.

“We can expect to generate a great amount of value from the technology that enables mass production of a cancer drug at low cost,” said the team.

link